JP7178108B2 - 血管造影において使用するためのデンドリマー組成物 - Google Patents
血管造影において使用するためのデンドリマー組成物 Download PDFInfo
- Publication number
- JP7178108B2 JP7178108B2 JP2019558350A JP2019558350A JP7178108B2 JP 7178108 B2 JP7178108 B2 JP 7178108B2 JP 2019558350 A JP2019558350 A JP 2019558350A JP 2019558350 A JP2019558350 A JP 2019558350A JP 7178108 B2 JP7178108 B2 JP 7178108B2
- Authority
- JP
- Japan
- Prior art keywords
- dendrimer
- composition
- integer
- subject
- dendrimers
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
- A61K49/0054—Macromolecular compounds, i.e. oligomers, polymers, dendrimers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
- A61K49/0032—Methine dyes, e.g. cyanine dyes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
- A61K49/0032—Methine dyes, e.g. cyanine dyes
- A61K49/0034—Indocyanine green, i.e. ICG, cardiogreen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
- A61K49/0041—Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal
- A61K49/0043—Fluorescein, used in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
- A61B3/10—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
- A61B3/102—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for optical coherence tomography [OCT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
- A61B3/10—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
- A61B3/12—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for looking at the eye fundus, e.g. ophthalmoscopes
- A61B3/1241—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for looking at the eye fundus, e.g. ophthalmoscopes specially adapted for observation of ocular blood flow, e.g. by fluorescein angiography
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0062—Arrangements for scanning
- A61B5/0066—Optical coherence imaging
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Eye Examination Apparatus (AREA)
- Polyamides (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762490936P | 2017-04-27 | 2017-04-27 | |
| US62/490,936 | 2017-04-27 | ||
| PCT/US2018/029882 WO2018201007A2 (en) | 2017-04-27 | 2018-04-27 | Dendrimer compositions for use in angiography |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020520393A JP2020520393A (ja) | 2020-07-09 |
| JP2020520393A5 JP2020520393A5 (cg-RX-API-DMAC7.html) | 2021-05-27 |
| JP7178108B2 true JP7178108B2 (ja) | 2022-11-25 |
Family
ID=63919237
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019558350A Active JP7178108B2 (ja) | 2017-04-27 | 2018-04-27 | 血管造影において使用するためのデンドリマー組成物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US11160881B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3615086A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7178108B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN110913916A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2018258654B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3061630C (cg-RX-API-DMAC7.html) |
| IL (1) | IL270169B2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2018201007A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS67656B1 (sr) | 2018-05-10 | 2026-02-27 | Regeneron Pharma | Formulacije koje sadrže visoke koncentracije fuzionog proteina vegf receptora |
| WO2021113662A2 (en) | 2019-12-04 | 2021-06-10 | Ashvattha Therapeutics, Inc. | Dendrimer compositions and methods for drug delivery to the eye |
| CN112023061B (zh) * | 2020-07-30 | 2022-07-12 | 东华大学 | 一种功能化树状大分子包裹金纳米颗粒/PD-L1 siRNA复合物及其制备和应用 |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010540664A (ja) | 2007-10-05 | 2010-12-24 | ウェイン ステート ユニバーシティー | 合成物の持続的な放出のためのデンドリマー |
| US20130165771A1 (en) | 2011-12-17 | 2013-06-27 | Ming Ni | Use of fitc-dextran as dye for fundus angiography and methods thereof |
| CN103804693A (zh) | 2014-01-24 | 2014-05-21 | 中国科学院化学研究所 | 树枝状聚缩酮及其制备方法和应用 |
| WO2014109927A1 (en) | 2013-01-11 | 2014-07-17 | The Regents Of The University Of Michigan | Synthesis and isolation of dendrimer based imaging systems |
| JP2017514347A (ja) | 2014-03-21 | 2017-06-01 | サン パテント トラスト | D2d通信におけるスケジューリング要求手順 |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2093165C1 (ru) | 1993-07-06 | 1997-10-20 | Линд Роберт Мейнгардтович | Средство для лечения конъюнктивитов |
| US6355677B1 (en) | 1998-09-28 | 2002-03-12 | The Johns Hopkins University | Adrenoleukodystrophy treatments and drug screening |
| US6312725B1 (en) | 1999-04-16 | 2001-11-06 | Cohesion Technologies, Inc. | Rapid gelling biocompatible polymer composition |
| US20030180250A1 (en) | 2002-03-22 | 2003-09-25 | Council Of Scientific And Industrial Research | Compositions and complexes containing a macromolecular compound as potential anti-inflammatory agents |
| US20040151754A1 (en) | 2002-12-20 | 2004-08-05 | Control Delivery Systems, Inc. | Steroid suspensions for intraocular use |
| EP1689354A4 (en) | 2003-11-20 | 2010-07-14 | Othera Holding Inc | REDUCTION OF CATARACTS, MACULAR GENERATION AND OTHER EYES DISEASES |
| US20050276917A1 (en) | 2004-06-15 | 2005-12-15 | Helene Bolm | Process for the preparation of powder coatings |
| EP1676569A1 (en) | 2004-12-30 | 2006-07-05 | Pevion Biotech Ltd. | Lyophilization of virosomes |
| CA2598430C (en) | 2005-04-20 | 2011-10-25 | Dendritic Nanotechnologies, Inc. | Dendritic polymers with enhanced amplification and interior functionality |
| US7674781B2 (en) | 2006-04-28 | 2010-03-09 | Heather Sheardown | Hyaluronic acid-retaining polymers |
| CN101495152A (zh) | 2006-05-22 | 2009-07-29 | 艾伦药物公司 | 通过三信反应制备作为vla-4拮抗剂的聚合物结合物的方法 |
| EP2261290B1 (en) | 2008-04-04 | 2016-02-24 | Konica Minolta IJ Technologies, Inc. | Nonaqueous ink jet ink, process for producing nonaqueous ink jet ink, and ink jet recording method |
| WO2009142754A1 (en) | 2008-05-22 | 2009-11-26 | Goverment Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Dendritic conjugates and methods of use |
| US20100015231A1 (en) | 2008-07-17 | 2010-01-21 | E.I. Du Pont De Nemours And Company | Low swell, long-lived hydrogel sealant |
| US8821870B2 (en) | 2008-07-18 | 2014-09-02 | Allergan, Inc. | Method for treating atrophic age related macular degeneration |
| WO2010039861A2 (en) | 2008-09-30 | 2010-04-08 | The Regents Of The University Of Michigan | Dendrimer conjugates |
| CA2767163A1 (en) | 2009-06-15 | 2010-12-23 | Wayne State University | Dendrimer based nanodevices for therapeutic and imaging purposes |
| US20120177593A1 (en) | 2009-07-20 | 2012-07-12 | The Regents Of The University Of Michigan | Synthesis of dendrimer conjugates |
| WO2011072290A2 (en) | 2009-12-11 | 2011-06-16 | The Regents Of The University Of Michigan | Targeted dendrimer-drug conjugates |
| WO2011123591A1 (en) | 2010-03-31 | 2011-10-06 | Wayne State University | Injectable dendrimer hydrogel nanoparticles |
| JP2013540748A (ja) | 2010-09-16 | 2013-11-07 | コーネル ユニバーシティー | 血液脳関門の透過性を調節するためのアデノシン受容体シグナル伝達の使用法 |
| WO2012142470A1 (en) | 2011-04-13 | 2012-10-18 | Massachusetts Institute Of Technology | Biocompatible adhesive materials and methods |
| US20130123330A1 (en) | 2011-07-15 | 2013-05-16 | Patrick Y. Lu | Dual Targeted siRNA Therapeutics for Treatment of Diabetic Retinopathy and Other Ocular Neovascularization Diseases |
| CN104781276A (zh) | 2012-08-14 | 2015-07-15 | 安吉奥开米公司 | 肽-树枝状聚合物结合物及其用途 |
| WO2014178892A1 (en) | 2013-05-03 | 2014-11-06 | Scanlan Thomas S | Use of sobetirome in the treatment of x-linked adrenolenoleukodystrophy |
| AU2014276379A1 (en) | 2013-06-07 | 2016-01-07 | The Administrators Of The Tulane Educational Fund | Analogs of pituitary adenylate cyclase-activating polypeptide (PACAP) and methods for their use |
| CN105813690A (zh) | 2013-08-21 | 2016-07-27 | 协和大学 | 树状聚合物-白藜芦醇复合物 |
| WO2015038493A1 (en) | 2013-09-10 | 2015-03-19 | The Research Foundation For The State University Of New York | Synthesis of novel asymmetric bow-tie pamam dendrimer-based conjugates for tumor-targeting drug delivery |
| EP3137116B1 (en) | 2014-04-30 | 2020-12-16 | The Johns Hopkins University | Dendrimer compositions and their use in treatment of diseases of the eye |
| US11918695B2 (en) | 2014-05-09 | 2024-03-05 | Yale University | Topical formulation of hyperbranched polymer-coated particles |
| CN103999853B (zh) | 2014-06-11 | 2015-07-22 | 中国农业大学 | 荧光树枝状纳米大分子在制备药物载体中的应用 |
| WO2016025745A1 (en) * | 2014-08-13 | 2016-02-18 | The Johns Hopkins University | Dendrimer compositions and use in treatment of neurological and cns disorders |
| EP3180031A1 (en) | 2014-08-13 | 2017-06-21 | The Johns Hopkins University | Selective dendrimer delivery to brain tumors |
| CN108289872B (zh) | 2015-10-29 | 2021-04-02 | 约翰霍普金斯大学 | 树枝状聚合物组合物和其在坏死性小肠结肠炎和其它胃肠道病症治疗中的用途 |
| CN108430514B (zh) | 2015-10-29 | 2023-11-03 | 约翰霍普金斯大学 | 用于治疗过氧化物酶体病症和脑白质营养不良的组合物和方法 |
| JP6986758B2 (ja) | 2016-02-08 | 2021-12-22 | ザ・ジョンズ・ホプキンス・ユニバーシティー | デンドリマー−生体接着性ポリマーヒドロゲルナノ接着剤およびその使用 |
| WO2019094952A1 (en) | 2017-11-10 | 2019-05-16 | The Johns Hopkins University | Dendrimer delivery system and methods of use thereof |
-
2018
- 2018-04-27 EP EP18791444.5A patent/EP3615086A4/en active Pending
- 2018-04-27 WO PCT/US2018/029882 patent/WO2018201007A2/en not_active Ceased
- 2018-04-27 AU AU2018258654A patent/AU2018258654B2/en active Active
- 2018-04-27 JP JP2019558350A patent/JP7178108B2/ja active Active
- 2018-04-27 IL IL270169A patent/IL270169B2/en unknown
- 2018-04-27 US US16/608,691 patent/US11160881B2/en active Active
- 2018-04-27 CN CN201880037028.9A patent/CN110913916A/zh active Pending
- 2018-04-27 CA CA3061630A patent/CA3061630C/en active Active
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010540664A (ja) | 2007-10-05 | 2010-12-24 | ウェイン ステート ユニバーシティー | 合成物の持続的な放出のためのデンドリマー |
| US20130165771A1 (en) | 2011-12-17 | 2013-06-27 | Ming Ni | Use of fitc-dextran as dye for fundus angiography and methods thereof |
| WO2014109927A1 (en) | 2013-01-11 | 2014-07-17 | The Regents Of The University Of Michigan | Synthesis and isolation of dendrimer based imaging systems |
| CN103804693A (zh) | 2014-01-24 | 2014-05-21 | 中国科学院化学研究所 | 树枝状聚缩酮及其制备方法和应用 |
| JP2017514347A (ja) | 2014-03-21 | 2017-06-01 | サン パテント トラスト | D2d通信におけるスケジューリング要求手順 |
Non-Patent Citations (3)
| Title |
|---|
| Raymond Iezzi et al.,Dendrimer-based targeted intravitreal therapy for sustained attenuation of neuroinflammation in retinal degeneration,Biomaterials ,2011年11月01日,vol.33,p.979-988 |
| Uri Soiberman et al.,Subconjunctival injectable dendrimer-dexamethasone gel for the treatment of corneal inflammation,Biomaterials,2017年02月16日,vol.125,p.38-53 |
| Wojciech G.Lesniak et al.,Biodistribution of Fluorescently Labeled PAMAM Dendrimers in Neonatal Rabbits: Effect of Neuroinflammation,molecular pharmaceutics,2013年10月11日,vol.10,p.4560-4571 |
Also Published As
| Publication number | Publication date |
|---|---|
| CA3061630C (en) | 2021-12-07 |
| AU2018258654A1 (en) | 2019-12-12 |
| CA3061630A1 (en) | 2018-11-01 |
| US20200179537A1 (en) | 2020-06-11 |
| EP3615086A4 (en) | 2021-01-06 |
| WO2018201007A3 (en) | 2019-01-03 |
| US11160881B2 (en) | 2021-11-02 |
| IL270169B2 (en) | 2024-08-01 |
| EP3615086A2 (en) | 2020-03-04 |
| IL270169A (cg-RX-API-DMAC7.html) | 2019-12-31 |
| AU2018258654B2 (en) | 2022-01-06 |
| IL270169B1 (en) | 2024-04-01 |
| CN110913916A (zh) | 2020-03-24 |
| JP2020520393A (ja) | 2020-07-09 |
| WO2018201007A2 (en) | 2018-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20230092699A1 (en) | Dendrimer compositions and their use in treatment of diseases of the eye | |
| Cheng et al. | pH-responsive multifunctional theranostic rapamycin-loaded nanoparticles for imaging and treatment of acute ischemic stroke | |
| Nguyen et al. | Gold nanorod enhanced photoacoustic microscopy and optical coherence tomography of choroidal neovascularization | |
| US10238756B2 (en) | Lipid nanoparticles and uses thereof | |
| CA2957940C (en) | Dendrimer compositions and use in treatment of neurological and cns disorders | |
| US20100034749A1 (en) | Use of a Cationic Collodal Preparation for the Diagnosis and Treatment of Ocular Diseases | |
| JP2007536272A (ja) | 近視の処置法 | |
| CA3066384A1 (en) | Linked and other ph-triggered compounds | |
| ES2848209T3 (es) | Direccionamiento específico de célula mediante sistemas portadores nanoestructurados | |
| JP7759322B2 (ja) | 眼に薬物送達するためのデンドリマー組成物および方法 | |
| CN107050020A (zh) | 用于治疗和诊断致盲性眼病的方法 | |
| CN103285408A (zh) | Fitc-葡聚糖在制备眼底血管造影剂方面的应用 | |
| Xin et al. | Ophthalmic drops with nanoparticles derived from a natural product for treating age-related macular degeneration | |
| Russell et al. | Fluorescent tracers for in vivo imaging of lymphatic targets | |
| US20100098637A1 (en) | Dye-loaded nanoparticle | |
| US20210236652A1 (en) | Nanoparticles for treatment of choroidal neovascularization and other indications | |
| JP2020520393A (ja) | 血管造影において使用するためのデンドリマー組成物 | |
| Li et al. | Zebrafish: a visual model to evaluate the biofate of transferrin receptor-targeted 7peptide-decorated coumarin 6 micelles | |
| Shi et al. | Recent advances in interventional fluorescence imaging: toward the precise visualization of transarterial mini-invasive delivery systems | |
| Spanò et al. | Enhancing thrombolysis safety in Post-Acute ischemic stroke with tissue plasminogen Activator-Associated microparticles | |
| US20120115771A1 (en) | Carrier | |
| CN118490640A (zh) | Rgd@lp-2-dg及其在制备血管新生病药物中的应用和制备方法 | |
| HK40026651A (en) | Dendrimer compositions for use in angiography | |
| McLean et al. | Targeted 8-arm PEG Nanosystems for Localization of Choroidal Neovascularization Macular Degeneration Model | |
| Neto | Drug Encapsulation in Extracellular Vesicles for Age-Related Macular Degeneration Treatment |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210419 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20210419 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20220316 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20220318 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20221021 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20221107 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7178108 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |